                               SEQUENCE LISTING

<110> PMV PHARMACEUTICALS, INC.
 
<120> COMBINATION THERAPY FOR TREATMENT OF CANCER

<130> 44727-714.601

<140> PCT/US2021/037473
<141> 2021-06-15

<150> 63/162,184
<151> 2021-03-17

<150> 63/043,342
<151> 2020-06-24

<160> 1     

<170> PatentIn version 3.5

<210> 1
<211> 219
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 1
Ser Ser Ser Val Pro Ser Gln Lys Thr Tyr Gln Gly Ser Tyr Gly Phe 
1               5                   10                  15      


Arg Leu Gly Phe Leu His Ser Gly Thr Ala Lys Ser Val Thr Cys Thr 
            20                  25                  30          


Tyr Ser Pro Ala Leu Asn Lys Met Phe Cys Gln Leu Ala Lys Thr Cys 
        35                  40                  45              


Pro Val Gln Leu Trp Val Asp Ser Thr Pro Pro Pro Gly Thr Arg Val 
    50                  55                  60                  


Arg Ala Met Ala Ile Tyr Lys Gln Ser Gln His Met Thr Glu Val Val 
65                  70                  75                  80  


Arg Arg Cys Pro His His Glu Arg Cys Ser Asp Ser Asp Gly Leu Ala 
                85                  90                  95      


Pro Pro Gln His Leu Ile Arg Val Glu Gly Asn Leu Arg Val Glu Tyr 
            100                 105                 110         


Leu Asp Asp Arg Asn Thr Phe Arg His Ser Val Val Val Pro Cys Glu 
        115                 120                 125             


Pro Pro Glu Val Gly Ser Asp Cys Thr Thr Ile His Tyr Asn Tyr Met 
    130                 135                 140                 


Cys Asn Ser Ser Cys Met Gly Gly Met Asn Arg Arg Pro Ile Leu Thr 
145                 150                 155                 160 


Ile Ile Thr Leu Glu Asp Ser Ser Gly Asn Leu Leu Gly Arg Asn Ser 
                165                 170                 175     


Phe Glu Val His Val Cys Ala Cys Pro Gly Arg Asp Arg Arg Thr Glu 
            180                 185                 190         


Glu Glu Asn Leu Arg Lys Lys Gly Glu Pro His His Glu Leu Pro Pro 
        195                 200                 205             


Gly Ser Thr Lys Arg Ala Leu Ser Asn Asn Thr 
    210                 215                 
